LUMOS PHARMA INC - Common Stock (LUMO)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock
Shares outstanding
8,122,625
Total 13F shares
3,276,996
Share change
+3,262,194
Total reported value
$27,855,000
Put/Call ratio
504%
Price per share
$8.50
Number of holders
37
Value change
+$27,728,971
Number of buys
35

Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q1 2020

As of 31 Mar 2020, LUMOS PHARMA INC - Common Stock (LUMO) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,276,996 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), NEA Management Company, LLC, Blackstone Group Inc, Lion Point Capital, LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Jefferies Group LLC, Investors Financial Group, LLC, BlackRock Inc., and MILLENNIUM MANAGEMENT LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.